Cargando…
Determining Immune and miRNA Biomarkers Related to Respiratory Syncytial Virus (RSV) Vaccine Types
Respiratory Syncytial Virus (RSV) causes serious respiratory tract illness and substantial morbidity and some mortality in populations at the extremes of age, i.e., infants, young children, and the elderly. To date, RSV vaccine development has been unsuccessful, a feature linked to the lack of bioma...
Autores principales: | Atherton, Lydia J., Jorquera, Patricia A., Bakre, Abhijeet A., Tripp, Ralph A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6794384/ https://www.ncbi.nlm.nih.gov/pubmed/31649663 http://dx.doi.org/10.3389/fimmu.2019.02323 |
Ejemplares similares
-
The Central Conserved Region (CCR) of Respiratory Syncytial Virus (RSV) G Protein Modulates Host miRNA Expression and Alters the Cellular Response to Infection
por: Bakre, Abhijeet A., et al.
Publicado: (2017) -
Pathobiology of Respiratory Syncytial Virus (RSV)
por: Tripp, Ralph A., et al.
Publicado: (2020) -
Role of Type I Interferon (IFN) in the Respiratory Syncytial Virus (RSV) Immune Response and Disease Severity
por: Hijano, Diego R., et al.
Publicado: (2019) -
Synthetic Biodegradable Microparticle and Nanoparticle Vaccines against the Respiratory Syncytial Virus
por: Jorquera, Patricia A., et al.
Publicado: (2016) -
Editorial: Understanding the Limitations of Current Influenza Vaccine Strategies and Future Development of More Efficacious Preventative and Therapeutic Interventions
por: Tripp, Ralph A., et al.
Publicado: (2019)